T1	Participants 668 708	8-week, double-blind, placebo-controlled
T2	Participants 961 1176	32 subjects with perennial allergic rhinitis and randomized them in a double-blinded, cross-over fashion, to receive placebo or fluticasone (50 micrograms a spray), 2 sprays each side everyday, using Balaam's design
